Proinflammatory IgG Fc structures in patients with severe COVID-19
Authors:
- Saborni ChakrabortySCSaborni Chakraborty
- Joseph GonzalezJGJoseph Gonzalez
- Karlie EdwardsKEKarlie Edwards
- Vamsee MallajosyulaVMVamsee Mallajosyula
- Anthony S. BuzzancoABAnthony S. Buzzanco
- Robert SherwoodRSRobert Sherwood
- Cindy BuffoneCBCindy Buffone
- Nimish KathaleNKNimish Kathale
- Susan ProvidenzaSPSusan Providenza
- Markus M. XieMXMarkus M. Xie
- Jason R. AndrewsJAJason R. Andrews
- Catherine A. BlishCBCatherine A. Blish
Preprint
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can cause Coronavirus Disease 2019 (COVID-19), which manifests with a range of severities from mild illness to life threatening pneumonia and multi-organ failure. Severe COVID-19 is characterized by an inflammatory signature including high levels of inflammatory cytokines, alveolar inflammatory infiltrates and vascular microthrombi. Here we show that severe COVID-19 patients produced a unique serologic signature, including increased IgG1 with afucosylated Fc glycans. This Fc modification on SARS-CoV-2 IgGs enhanced interactions with the activating FcγR, FcγRIIIa; when incorporated into immune complexes, Fc afucosylation enhanced production of inflammatory cytokines by monocytes, including IL-6 and TNF. These results show that disease severity in COVID-19 correlates with the presence of afucosylated IgG1, a pro-inflammatory IgG Fc modification.Keywords
All Related Versions
- Published version: Nature Immunology, 22 (1), 67.
This publication has 26 references indexed in Scilit:
- Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort studyThe Lancet Infectious Diseases, 2020
- Maternal Anti-Dengue IgG Fucosylation Predicts Susceptibility to Dengue Disease in InfantsCell Reports, 2020
- SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test SetupCurrent Protocols in Microbiology, 2020
- IgG Fc Glycosylation in Human Immunity2019
- Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early ChildhoodJournal of Proteome Research, 2016
- Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine EfficacyCell, 2015
- High-Throughput IgG Fc N-Glycosylation Profiling by Mass Spectrometry of GlycopeptidesJournal of Proteome Research, 2013
- Human IgG Fc-glycosylation profiling reveals associations with age, sex, female sex hormones and thyroid cancerJournal of Proteomics, 2012
- PI3K limits TNF‐α production in CD16‐activated monocytesEuropean Journal of Immunology, 2009
- Fc‐Receptors as Regulators of Immunity2007